Create a free Feed & Grain account to continue reading

Kerry Acquires Enzyme Biotechnology Companies

Enzymes increasingly play a vital role as biocatalysts that deliver many benefits

Kerry group logo

Kerry has made two significant biotechnology acquisitions that will expand its expertise, technology portfolio and manufacturing capabilities.

The company has reached agreement to acquire the leading biotechnology innovation company, c-LEcta while also confirming that it has acquired the Mexican-based enzyme manufacturer, Enmex.

c-LEcta is a leading biotechnology innovation company specializing in precision fermentation, optimized bio-processing and bio-transformation for the creation of high-value targeted enzymes and ingredients.